Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 3/20 | 0.39 |
| ▸ | SCD | O00767 | 5/20 | 0.37 |
| ▸ | SCD5 | Q86SK9 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.36 |
| ▸ | ITK | Q08881 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | RPS6KA2 | Q15349 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6648284 | 0.85 | ALDH1A1 (0.40) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6647857 | 0.81 | SCN10A (0.44) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6647854 | 0.79 | ALDH1A1 (0.44) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6645258 | 0.78 | ALDH1A1 (0.36) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6647313 | 0.78 | SCD (0.40) | SCDSCD5MAPTSMN1; SMN2AURKA | |
| SCHEMBL7201171 | 0.77 | SCD (0.43) | SCDSCD5MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL6648250 | 0.75 | L3MBTL1 (0.43) | MAPTAURKAALDH1A1KMT2ARAB9A | |
| SCHEMBL6645806 | 0.73 | MAPT (0.34) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6648297 | 0.73 | SCN10A (0.51) | SCN10AMAPTSMN1; SMN2TP53ALDH1A1 | |
| SCHEMBL6645504 | 0.72 | TRPV4 (0.42) | SCDSCD5MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040133008-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133008-A1 | Amide compounds | APOB, APOL1, LDLR | SCN10A 1201/4885SCD 2840/4885SCD5 3643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.